Detalhe da pesquisa
1.
STAT5 activation promotes progression and chemotherapy resistance in early T-cell precursor acute lymphoblastic leukemia.
Blood
; 142(3): 274-289, 2023 07 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36989489
2.
Acquired mutations in BAX confer resistance to BH3-mimetic therapy in acute myeloid leukemia.
Blood
; 141(6): 634-644, 2023 02 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36219880
3.
Intact TP-53 function is essential for sustaining durable responses to BH3-mimetic drugs in leukemias.
Blood
; 137(20): 2721-2735, 2021 05 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33824975
4.
Putting the STING back into BH3-mimetic drugs for TP53-mutant blood cancers.
Cancer Cell
; 42(5): 850-868.e9, 2024 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38670091
5.
Pharmacologic Reduction of Mitochondrial Iron Triggers a Noncanonical BAX/BAK-Dependent Cell Death.
Cancer Discov
; 12(3): 774-791, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862195
6.
Epigenetic Activation of Plasmacytoid DCs Drives IFNAR-Dependent Therapeutic Differentiation of AML.
Cancer Discov
; 12(6): 1560-1579, 2022 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35311997
7.
Small molecule inhibition of Dynamin-dependent endocytosis targets multiple niche signals and impairs leukemia stem cells.
Nat Commun
; 11(1): 6211, 2020 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33277497
8.
Cotargeting BCL-2 and MCL-1 in high-risk B-ALL.
Blood Adv
; 4(12): 2762-2767, 2020 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32569380
9.
High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.
J Clin Invest
; 126(12): 4569-4584, 2016 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27797342
10.
Author Correction: Small molecule inhibition of Dynamin-dependent endocytosis targets multiple niche signals and impairs leukemia stem cells.
Nat Commun
; 12(1): 1288, 2021 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33608527